Public company Propanc Biopharma announces plans to acquire $100 million Ethereum
2025-09-02 13:10:43
Biopharmaceutical company Propanc Biopharma (NASDAQ: PPCB) today (Sept 2) announced plans to acquire $100 million worth of Ethereum over the next 12 months. The company says the move will strengthen its corporate strategy across multiple areas, including cryptocurrency investments, drug development, and asset acquisitions.
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
